Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

Antman, EM; Morrow, DA; McCabe, CH; Murphy, SA; Ruda, M; Sadowski, Z; Budaj, A; Lopez-Sendon, JL; Guneri, S; Jiang, F; White, HD; Fox, KAA; Braunwald, E

doi:10.1056/nejmoa060898

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

Antman E., Morrow D., McCabe C., Murphy S., Ruda M., Sadowski Z., ...Daha Fazla

NEW ENGLAND JOURNAL OF MEDICINE, cilt.354, sa.14, ss.1477-1488, 2006 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 354 Sayı: 14
Basım Tarihi: 2006
Doi Numarası: 10.1056/nejmoa060898
Dergi Adı: NEW ENGLAND JOURNAL OF MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1477-1488
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients with ST-elevation myocardial infarction. We compared a low-molecular-weight heparin, enoxaparin, with unfractionated heparin for this purpose.